NCT00692705View on ClinicalTrials.gov

Positron Emission Tomography (PET) Study With [11C]AZD2995 and [11C]AZD2184, Candidate PET Ligands for β Amyloid

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Alzheimer´s Disease
Interventions
DRUG

Radioligand (11C)AZD2995

Single dose of i.v solution. 1-2 times for AD patients. Once for healthy volunteers.

DRUG

Radioligand (11C)AZD2184

Single dose of i.v solution. Once for AD patients respective healthy volunteers.

Trial Locations (1)

Unknown

Research Site, Stockholm

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY